Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Ajinomoto Co. Inc.
DescriptionOral agent for improving digestive function
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationDyspepsia
Indication DetailsTreat functional dyspepsia (FD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today